supplements

Resveratrol vs Pterostilbene: Which Sirtuin Activator Is Worth Taking?

Resveratrol put longevity supplements on the map. Pterostilbene is its more bioavailable cousin. Here's what the science actually shows — and which one to take.

Dr. Sarah Chen5 min read
Written by our Chief Medical Reviewer
Every claim cross-checked against peer-reviewed literature. Our process
resveratrolpterostilbenesirtuinlongevitysupplementsanti-agingNMN
Resveratrol vs Pterostilbene: Which Sirtuin Activator Is Worth Taking?

Quick Verdict

76/100

Pterostilbene outperforms resveratrol on bioavailability (4x) and duration of action. Neither has the dramatic human lifespan extension data that early animal studies suggested. Both remain reasonable additions to a longevity stack at evidence-based doses — pterostilbene is the better buy per milligram of bioavailable compound.

Top Picks

We may earn a commission if you buy through our links — at no extra cost to you. Commissions never influence rankings or scores. How we stay independent

Best Combined Stack

Wonderfeel Youngr NMN (with Resveratrol)

Wonderfeel · $88.00

85

Pros

  • NMN + resveratrol + ergothioneine in one capsule
  • Trans-resveratrol (active form) verified
  • Third-party tested
  • Designed by longevity researchers

Cons

  • Premium price
  • Lower resveratrol dose than standalone products
Best Pterostilbene Option

Tru Niagen + Pterostilbene Stack

ChromaDex · $40.00

82

Pros

  • Pterostilbene at 50mg/day (evidence-based dose)
  • Better bioavailability than resveratrol
  • More affordable than resveratrol equivalents

Cons

  • Less research than resveratrol overall
  • Human RCT data still emerging

The Resveratrol Story: Hype, Hope, and Where We Are Now

In 2006, David Sinclair's lab published a landmark paper: resveratrol — a compound found in red wine — extended lifespan in obese mice by 24% and improved their metabolic health dramatically. The media coverage was extraordinary. Red wine went from a guilty pleasure to a longevity intervention. Supplement companies sold out within days.

Fifteen years later, the picture is more nuanced. Here is what we actually know.


What Resveratrol Is

Resveratrol is a polyphenol produced by plants under stress — found in:

  • Red grapes (and red wine — but at 1–2mg/glass, far below therapeutic doses)
  • Blueberries and bilberries
  • Peanuts and peanut butter
  • Japanese knotweed (the primary commercial source for supplements)

Active form: trans-resveratrol (not cis-resveratrol). Many supplements contain a mixture — quality matters here.


The Core Mechanism: Sirtuin Activation

Resveratrol activates sirtuins — particularly SIRT1 — a family of proteins that regulate gene expression, DNA repair, mitochondrial biogenesis, and cellular stress responses. Sirtuins are sometimes called "longevity genes" because they are consistently upregulated by caloric restriction across species.

The theory: resveratrol mimics caloric restriction by activating SIRT1 without requiring actual food restriction. This was the basis of enormous excitement in the early 2000s.

What actually happened:

Early resveratrol studies used SIRT1 activation assays that were later found to be artefacts of the fluorescent label used in the assay. Subsequent work suggested resveratrol may still activate sirtuins indirectly — via AMPK — but the direct sirtuin activation story became more complicated.

Sinclair himself continued advocating for resveratrol alongside NMN (which raises NAD+, the substrate sirtuins require to function). His personal protocol: 1g resveratrol/day with NMN and yogurt (fat increases resveratrol absorption).


The Human Evidence

What it shows:

  • Cardiovascular: Several small RCTs show improved endothelial function and reduced LDL oxidation at doses of 100–500mg/day
  • Anti-inflammatory: Reduces CRP and other inflammatory markers in metabolic syndrome patients
  • Blood glucose: Improves insulin sensitivity in some studies, particularly in type 2 diabetics
  • Cognitive: One RCT (Turner et al., 2015) showed improved memory performance in postmenopausal women

What it does not show (yet):

  • Lifespan extension in humans (no RCT possible on this endpoint)
  • The dramatic effect sizes seen in the 2006 obese mouse study
  • Consistent results across all populations — metabolically unhealthy individuals seem to respond better

The bioavailability problem:

Resveratrol is rapidly metabolised and conjugated in the gut wall and liver. Oral bioavailability of free resveratrol is very low — approximately 1% reaches systemic circulation in unmodified form. The remainder is converted to sulphate and glucuronide metabolites whose biological activity is debated.

Taking resveratrol with a high-fat meal improves absorption meaningfully.


Pterostilbene: The Superior Analogue

Pterostilbene is resveratrol's methylated cousin — found in blueberries and grapes at low concentrations. Structurally, it has two methoxy groups where resveratrol has two hydroxyl groups.

These structural changes have significant practical consequences:

Bioavailability: ~80% oral bioavailability vs approximately 20% for resveratrol (accounting for metabolites) and ~1% as free resveratrol Half-life: 105 minutes vs 14 minutes for resveratrol Lipophilicity: More fat-soluble, improving cell membrane penetration

Result: Per milligram consumed, pterostilbene delivers significantly more active compound to target tissues than resveratrol.

Pterostilbene Evidence

  • Similar SIRT1/AMPK activation profile to resveratrol
  • Improved cognitive function in animal models of ageing
  • Human data: one RCT (Dellinger et al., 2017) in 80 participants showed improved blood pressure at 50mg/day without adverse effects
  • Appears to cross the blood-brain barrier more effectively than resveratrol — relevant for neuroprotection

Caveat: Pterostilbene has less total research than resveratrol. Resveratrol has hundreds of published studies; pterostilbene has dozens. More research is underway.


Resveratrol vs Pterostilbene: Head to Head

| | Resveratrol | Pterostilbene | |---|---|---| | Bioavailability | ~1% free (~20% as metabolites) | ~80% | | Half-life | ~14 minutes | ~105 minutes | | Human RCT data | Extensive (hundreds of studies) | Limited but growing | | Cost per effective dose | Higher (need 250–1000mg) | Lower (50–150mg sufficient) | | Blood-brain barrier | Poor | Better | | Safety profile | Excellent | Excellent |

Practical conclusion: For most people, pterostilbene is the better choice at 50–100mg/day. If using resveratrol, take 250–500mg with a fat-containing meal and ideally alongside NMN.


Practical Protocol

Option A — Resveratrol:

  • 250–500mg trans-resveratrol daily
  • Take with a meal containing fat (olive oil, nuts, avocado)
  • Verify label says trans-resveratrol (not just "resveratrol")
  • Stack with NMN for synergistic NAD+/sirtuin support

Option B — Pterostilbene:

  • 50–150mg/day
  • Can be taken with or without food (better bioavailability reduces dependence on fat)
  • Look for pTeroPure brand ingredient (verified purity)

Option C — Both at lower doses:

  • Resveratrol 150mg + Pterostilbene 50mg daily
  • The complementary pharmacokinetics (resveratrol peaks fast, pterostilbene sustains) may provide broader coverage

Honest Assessment

Resveratrol was once the most hyped longevity supplement in history. The hype has been revised downward — but not to zero. The human evidence for cardiovascular and metabolic benefits at therapeutic doses is real, if modest. It is not going to give you 24% lifespan extension. It may meaningfully improve metabolic and cardiovascular biomarkers.

Pterostilbene is pharmacologically superior and deserves more attention than it currently receives. If you are choosing one, choose pterostilbene. If you are taking resveratrol because of Sinclair's protocol, continue — but ensure you are taking it correctly (high dose, with fat, alongside NMN).

Both compounds are safe at evidence-based doses. Neither requires cycling.

About the Author

SC

Dr. Sarah Chen

Chief Medical Reviewer

MD with 12 years in preventive medicine and longevity research. Former researcher at UCSF. Specialises in metabolic health, diagnostics, and evidence-based supplementation.

MD, Internal Medicine. Board-certified. Former UCSF researcher.Meet the team

Continue Reading

Related Articles